News coverage about Precipio (NASDAQ:PRPO) has trended somewhat positive this week, Accern reports. The research firm rates the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Precipio earned a media sentiment score of 0.08 on Accern’s scale. Accern also gave news stories about the biotechnology company an impact score of 47.5646752152396 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
These are some of the media headlines that may have impacted Accern Sentiment’s analysis:
Get Precipio alerts: Precipio Updates Commercial Pipeline for its ICE-COLD PCR�� Liquid Biopsy Technology (finance.yahoo.com) Financial Contrast: Precipio (PRPO) & Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) (americanbankingnews.com) Precipio Inc. Announces Adjournment of Annual Meeting of Shareholders (markets.financialcontent.com) Precipio Inc (PRPO) Short Interest Update (americanbankingnews.com) Contrasting Bruker (BRKR) and Precipio (PRPO) (americanbankingnews.com)Precipio traded down $0.03, hitting $0.44, during midday trading on Tuesday, according to MarketBeat.com. 897,281 shares of the company’s stock traded hands, compared to its average volume of 1,249,438. The company has a quick ratio of 0.12, a current ratio of 0.14 and a debt-to-equity ratio of 0.22. Precipio has a one year low of $0.36 and a one year high of $28.16.
Separately, ValuEngine upgraded shares of Precipio from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd.
About Precipio
Precipio, Inc provides platform to eradicate the problem of misdiagnosis within academic institutions. The company also delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
